MSB 3.76% $1.03 mesoblast limited

Testimonial MPC-150-IM clinical trial phase 2

  1. 129 Posts.
    A very interesting testimonial and video featuring a CHF affected person demonstrating remarkable recovery during a clinical trial using Mesoblast MPC's  at a 150m dose.  Unlikely to be placebo. Silviu and the entire Board will be most encouraged by this.



    Its my understanding that success with CHF will give great confidence in the many other conditions that Mesoblast will be able to address.
    On a relative basis it's also my understanding that CHF has been seen as the  ultimate test of the functionality of our cells.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.